Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
| 15.11.2024 20:08:36 | Diff. -5,79 | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 160,38USD | -3,48% | 9.929 Umsatz: 1,61 Mio. |
-Geld Vol: - | -Brief Vol: - | 23,31 Mrd.USD | - | 19,95 |
Aktiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.641,6000 | 1.571,4000 | 1.742,2000 | 1.750,7000 | 1.765,6830 | ||||||
| Immaterielle Vermögensgegenstände | 1.772,8000 | 1.608,2000 | 1.631,5000 | 4.474,7000 | 4.028,5070 | ||||||
| Finanzanlagen | 743,1000 | 1.416,7000 | 2.036,7000 | 625,8000 | 1.470,6520 | ||||||
| Anlagevermögen | - | - | - | - | 9.643,8860 | ||||||
| Vorräte | 289,1000 | 326,8000 | 447,4000 | 659 | 804,0220 | ||||||
| Forderungen | 605,3000 | 584,6000 | 686,8000 | 824,4000 | 1.292,4450 | ||||||
| Liquide Mitteln | 759,6000 | 514,5000 | 570,7000 | 602,6000 | 1.204,9240 | ||||||
| Umlaufvermögen | 2.540,4000 | 2.975,4000 | 3.244,3000 | 3.184,9000 | 4.672,6730 | ||||||
| Aktiva, gesamt | 8.092,5000 | 9.049,6000 | 10.130,1000 | 11.863,3000 | 14.316,5590 | ||||||
Passiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 162,5000 | 186,4000 | 204 | 219,9000 | 229,1780 | ||||||
| Langfristige Schulden | - | - | - | 592,4000 | 582,0610 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 0.0000 | 0.0000 | 0.0000 | 592,4000 | 582,1000 | ||||||
| Rückstellungen | 285,5000 | 294,5000 | 237,4000 | 412,3000 | 218,8000 | ||||||
| Verbindlichkeiten | 2.643,2000 | 2.622,6000 | 3.166,3000 | 3.242,5000 | 3.502,5190 | ||||||
| Gezeichnetes Kapital | - | - | - | - | ,1290 | ||||||
| Eigenkapital | 5.449,4000 | 6.427 | 6.963,8000 | 8.620,8000 | 10.814,0400 | ||||||
| Minderheitenanteile | 52,9000 | 1,5000 | 2,3000 | ,6000 | 5,0300 | ||||||
| Passiva, gesamt | 8.092,5000 | 9.049,6000 | 10.130,1000 | 11.863,3000 | 14.316,5590 | ||||||
Gewinn- und Verlustrechnung
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 4.716,4000 | 5.048,6000 | 5.516,5000 | 6.932,2000 | 9.703,3240 | ||||||
| Abschreibungen (Gesamt) | 208,9000 | 208,6000 | 202,2000 | 342,9000 | 688,1500 | ||||||
| Betriebsergebnis | 1.248,9000 | 1.724,7000 | 1.809,1000 | 2.490,6000 | 3.972,4140 | ||||||
| Zinsergebnis | - | - | - | - | -17,3000 | ||||||
| Ergebnis vor Steuern | 1.229,9000 | 1.711,2000 | 1.855,1000 | 2.480,6000 | 3.946,6330 | ||||||
| Ertragsteuern | 331,3000 | 444,5000 | 470,6000 | 601 | 989,9420 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 106,7000 | -32,3000 | 0.0000 | 0.0000 | 6,7810 | ||||||
| Konzernjahresüberschuss | 1.005,3000 | 1.234,4000 | 1.380 | 1.862,3000 | 2.934,7840 | ||||||
Pro Aktie
Cash Flow
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 1.624,7000 | 1.727,7000 | 1.879,9000 | 2.345,1000 | 2.942,1150 | ||||||
| Cash Flow aus Investitionstätigkeit | 345,3000 | -1.650,3000 | -950,3000 | -1.604,7000 | -1.542,9760 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.784,9000 | -319,9000 | -877,5000 | -716,5000 | -755,8730 | ||||||
| Veränderung der liquiden Mittel | 185,1000 | -242,4000 | 52,1000 | 23,9000 | 643,2660 | ||||||
| Anzahl der Mitarbeiter | 4.850 | 5.000 | 5.950 | 6.850 | 7.550 | ||||||
